INmune Bio Scheduled to Post Quarterly Earnings on Thursday
| INMB Stock | USD 5.30 0.27 4.85% |
About 62% of INmune Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding INmune Bio suggests that many traders are alarmed. The current market sentiment, together with INmune Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use INmune Bio stock news signals to limit their universe of possible portfolio assets.
INmune |
INmune Bio will release its earnings data after the market closes on Thursday, October 31st. Analysts expect INmune Bio to post earnings of per share for the quarter. Individual interested in participating in the companys earnings conference call can do so using this link. INmune Bio NASDAQINMB Get
Read at thelincolnianonline.com
 |
INmune Bio Fundamental Analysis
We analyze INmune Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INmune Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INmune Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
INmune Bio is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
INmune Bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with INmune Bio stock to make a market-neutral strategy. Peer analysis of INmune Bio could also be used in its relative valuation, which is a method of valuing INmune Bio by comparing valuation metrics with similar companies.
Peers
INmune Bio Related Equities
| ANEB | Anebulo Pharmaceuticals | 0.61 |
| ||
| AVTE | Aerovate Therapeutics | 1.49 |
| ||
| CGTX | Cognition Therapeutics | 3.66 |
| ||
| ANTX | AN2 Therapeutics | 3.70 |
| ||
| BIVI | Biovie | 4.45 |
| ||
| PYPD | PolyPid | 4.47 |
| ||
| ANIX | Anixa Biosciences | 4.66 |
| ||
| TCRX | Tscan Therapeutics | 5.32 |
| ||
| SAVA | Cassava Sciences | 6.29 |
| ||
| DRMA | Dermata Therapeutics | 7.35 |
| ||
| CUE | Cue Biopharma | 9.38 |
| ||
| INAB | In8bio | 11.43 |
| ||
| AVXL | Anavex Life | 15.08 |
|
Complementary Tools for INmune Stock analysis
When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |